Showing results (251-260 of 281) with videos related to
Sort By:
Pageof 29
JAMA|October 17, 2023
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-AnalysisStephen P Juraschek, Jiun-Ruey Hu, Jennifer L Cluett, et al.Kidney International|February 27, 2021
Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney DiseaseAlfred K Cheung, Tara I Chang, William C Cushman, et al.Annals of Internal Medicine|June 21, 2021
Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice GuidelineCharles R V Tomson, Alfred K Cheung, Johannes F E Mann, et al.Hypertension (Dallas, Tex. : 1979)|July 26, 2006
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trialFrans H H Leenen, Chuke E Nwachuku, Henry R Black, et al.American Heart Journal|June 4, 2014
Proceedings from Duke resistant hypertension think tankSreekanth Vemulapalli, Jamy Ard, George L Bakris, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 13, 2012
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialWilliam C Cushman, Barry R Davis, Sara L Pressel, et al.Journal of the American College of Cardiology|September 1, 2024
Efficacy and Safety of a Novel Low-Dose Triple Single-Pill Combination Compared With Placebo for Initial Treatment of HypertensionAnthony Rodgers, Abdul Salam, Aletta E Schutte, et al.Journal of the American College of Cardiology|January 26, 2019
Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert PanelPaul Muntner, Paula T Einhorn, William C Cushman, et al.European Heart Journal|November 16, 2020
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metforminGiulia Ferrannini, Hertzel Gerstein, Helen Martina Colhoun, et al.Circulation|March 19, 2019
Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO TrialMichel Azizi, Roland E Schmieder, Felix Mahfoud, et al.Pageof 29